Clinical use of bone densitometry: Scientific review

JAMA

Volumn 288, Issue 15, 2002, Pages 1889-1897

  Cummings, Steven R ^a,b   Bates, David ^c   Black, Dennis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCITONIN; RALOXIFENE; RISEDRONIC ACID;

ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DENSITOMETRY; ESTROGEN THERAPY; HIP FRACTURE; HUMAN; MORBIDITY; PATIENT MONITORING; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; VERTEBRA FRACTURE;

EID: 0037120864     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.15.1889     Document Type: Article

References (73)

1. Ray NF, Chan JK, Thamer M, Melton LJ III. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:24-35.
2. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7:221-227.
3. Nevitt M, Ettinger B, Black D, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998;128:793-800.
4. Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646-650.
5. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312: 1254-1259.
6. Woodhouse A, Black DM. BMD at various sites for the prediction of hip fracture: a meta-analysis [abstract]. J Bone Miner Res. 2000;15:S145.
7. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet. 1993;341:72-75.
8. Eddy D, Johnston C, Cummings SR, et al. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int. 1998;8:S7-S80.
9. US Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002;137: 526-528.
10. Courtney AC, Wachtel EF, Myers ER, Hayes WC. Age-related reduction in the strength of the femur tested in a fall-loading configuration. J Bone Joint Surg Am. 1995;77:387-395.
11. Lotz JC, Hayes WC. The use of quantitative computed tomography to estimate risk of fracture of the hip from falls. J Bone Joint Surg Am. 1990;72:689-700.
12. Lang TF, Keyak JH, Heitz MW, et al. Volumetric quantitative computed tomography of the proximal femur: precision and relation to bone strength. Bone. 1997;21:101-108.
13. Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761-1768.
14. Russell-Aulet M, Wang J, Thornton J, Colt EWD, Pierson RN Jr. Bone mineral density and mass by total-body dual-photon absorptiometry in normal white and Asian men. J Bone Miner Res. 1991;6:1109-1113.
15. Russell-Aulet M, Wang J, Thornton JC, Colt EWD, Pierson RN Jr. Bone mineral density and mass in a cross-sectional study of white and Asian women. J Bone Miner Res. 1993;8:575-582.
16. Bauer DC, Gluer CC, Cauley JA, et al. Broad-band ultrasound attenuation predicts fractures strongly and independently of densitometry in older women: a prospective study. Arch Intern Med. 1997;157:629-634.
17. Black D, Nevitt M, Cummings SR. Bone densitometry and spine films. In: Cummings SR, Cosman F, Jamal S, eds. Osteoporosis: An Evidence-Based Guide to Prevention and Management. Philadelphia, Pa: American College of Physicians; 2002:29-58.
18. Grampp S, Genant HK, Mathur A, et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 1997; 12:697-711.
19. Steiger P, Cummings SR, Black DM, Spencer NE, Genant HK. Age-related decrements in bone mineral density in women over 65. J Bone Miner Res. 1992; 7:625-632.
20. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286:2815-2822.
21. Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom. 1999;2:343-350.
22. Lang TF, Li J, Harris ST, Genant HK. Assessment of vertebral bone mineral density using volumetric quantitative CT. J Comput Assist Tomogr. 1999;23: 130-137.
23. Yang S-O, Hagiwara S, Engelke K. Radiographic absorptiometry for bone mineral measurement of the phalanges: precision and accuracy study. Radiology. 1994;192:857-859.
24. Bouxsein ML, Palermo L, Yeung C, Black DM. Digital x-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the Study of Osteoporotic Fractures. Osteoporos Int. 2002;13:358-365.
25. Singh M, Nagrath AR, Maini PS. Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg Am. 1970; 52:457-467.
26. Haberg L, Nilsson BE. Can fracture of the femoral neck be predicted? Geriatrics. April 1977:55-61.
27. Gluer C, Cummings S, Pressman A, et al. Prediction of hip fractures from pelvic radiographs: the study of osteoporotic fractures. J Bone Miner Res. 1994;9: 671-677.
28. Kaufman JJ, Einhorn TA. Ultrasound assessment of bone. J Bone Miner Res. 1993;8:517-525.
29. Gluer CC, Vahlensieck M, Faulkner KG, Engelke K, Black D, Genant HK. Site-matched calcaneal measurements of broad-band ultrasound attenuation and single x-ray absorptiometry: do they measure different skeletal properties? J Bone Miner Res. 1992;7: 1071-1079.
30. Gregg EW, Kriska AM, Salamone LM, et al. The epidemiology of quantitative ultrasound: a review of the relationships with bone mass, osteoporosis and fracture risk. Osteoporos Int. 1997;7:89-99.
31. Hans D, Dargent-Molina P, Schott AM, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the Epidos Prospective Study. Lancet. 1996;348:511-514.
32. Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804-1809.
33. Wasnich RD, Ross PD, Davis JW, Vogel JM. A comparison of single and multi-site BMC measurements for assessment of spine fracture probability. J Nucl Med. 1989;30:1166-1171.
34. Black DM, Cummings SR, Melton LJ III. Appendicular bone mineral and a woman's lifetime risk of hip fracture. J Bone Miner Res. 1992;7:639-646.
35. Black D, Cummings S, Genant H, Nevitt M, Palermo L, Browner W. Axial and appendicular bone density predict fractures in older women. J Bone Miner Res. 1992;7:633-638.
36. Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston CC Jr. Predictors of bone mass in perimenopausal women: a prospective study of clinical data using photon absorptiometry. Ann Intern Med. 1990; 112:96-101.
37. Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. Ann Intern Med. 1993;118:657-665.
38. Orwoll ES, Bauer DC, Vogt TM, Fox KM. Axial bone mass in older women: Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1996;124:187-196.
39. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114: 919-923.
40. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new deformities but not wrist fractures: Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14:821-828.
41. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-739.
42. Burger H, De Laet CEDH, Weel AEAM, Hofman A, Pols HAP. Added value of bone mineral density in hip fracture risk scores. Bone. 1999;25:369-374.
43. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med. 1995;332:767-773.
44. Dargent-Molina P, Schott AM, Hans D, for the EPIDOS Study Group. Separate and combined value of bone mass and gait speed measurements in screening for hip fracture risk: results from the EPIDOS Study. Osteoporos Int. 1999;9:188-192.
45. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the Epidos Prospective Study. J Bone Miner Res. 1996;11:1531-1538.
46. Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women: Study of Osteoporotic Fractures Research Group N Engl J Med. 1998; 339:733-738
47. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001;12:519-528.
48. Kanis JA, Melton L III, Christiansen C, Johnston CC Jr, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;8:1137-1141.
49. Melton LJ, Chrischilles EA, Cooper C, Lane AW, Riggs BL. How many women have osteoporosis? J Bone Miner Res. 1992;7:1005-1010.
50. Melton LJ. The prevalence of osteoporosis. J Bone Miner Res. 1997;12:1769-1771.
51. Clowes JA, Eastell R. The laboratory and clinical assessment of osteoporosis and fracture risk: markers of bone turnover and the laboratory evaluation of secondary osteoporosis. In: Cummings SR, Cosman F, Jamal S, eds. Osteoporosis: An Evidence-Based Approach to the Prevention of Fractures. Philadelphia, Pa: American College of Physicians; 2002:59-82.
52. Ismail AA, Cooper C, Felsenberg D, et al. Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss: European Vertebral Osteoporosis Study Group. Osteoporos Int. 1999;9:206-213.
53. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group. Lancet. 1996; 348:1535-1541.
54. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998; 280:2077-2082.
55. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial: Multiple Outcomes of Raloxifene Evaluation (MORE) investigators. JAMA. 1999;282:637-645.
56. Harris S, Watts N, Genant H, et al. Effects of rised-ronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA. 1999;282:1344-1352.
57. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women: Hip Intervention Program Study Group. N Engl J Med. 2001;344:333-340.
58. Chesnut CH III, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study. Am J Med. 2000;109:267-276.
59. National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis. Belle Mead, NJ: Excerpta Medica Inc; 1998.
60. Orwoll ES, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604-610.
61. Writing Group for the PEPI. Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/progestin Interventions (PEPI) Trial. JAMA. 1996;276:1389-1396.
62. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
63. Nelson HD, Rizzo J, Harris E, et al. Osteoporosis and fractures in women using estrogen. J Bone Miner Res. In press.
64. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR, for the Study of Osteoporotic Fractures Research Group. Estrogen replacement therapy and fractures in older women. Ann Intern Med. 1995; 122:9-16.
65. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 1993;329:1141-1146.
66. Cummings SR, Palermo L, Browner WS, et al. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. JAMA. 2000;283:1318-1321.
67. Chapurlat R, Palermo L, Ramsay P, Cummings SR. Are non-responders responding? risk of fractures of those who lose bone with alendronate. J Bone Miner Res. In press.
68. Gluer CC. Monitoring skeletal changes by radiological techniques. J Bone Miner Res. 1999;14:1952-1962.
69. Ensrud KE, Palermo L, Black DM, et al. Hip and calcaneal bone loss increase with advancing age: Iongitudinal results from the Study of Osteoporotic Fractures. J Bone Miner Res. 1995;10:1778-1787.
70. Nevitt MC, Johnell O, Black DM, Erisrud K, Genant HK, Cummings SR. Bone mineral predicts non-spine fractures in very elderly women. Osteoporos Int. 1994; 4:325-331.
71. van Staa TP, Leufkens HG, Cooper C, Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res. 2001;16:581-588.
72. Fauikner KG. Update on bone density measurement. Rheum Dis Clin North Am. 2001;27:81-99,
73. Kanis JA, Gluer CC. An update on the diagnosis and assessment of osteoporosis with densitometry: committee of scientific advisors, International Osteoporosis Foundation. Osteoporos Int. 2000;11:192-202.